Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-01Clinical Trial Update: FCI Effectiveness in NAFLD Stratification [NA]
The clinical trial NCT05827432 evaluating FCI effectiveness in stratifying Non-Alcoholic Fatty Liver Disease has been withdrawn by the spons…
-
CLINICAL_TRIALS withdrawal · 2026-03-11Clinical Trial Update: Assessment of Fatty Liver With Thermo-acoustic Device
A clinical trial evaluating a thermo-acoustic device for fatty liver diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-10-02Clinical Trial Update: Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese Children [NA]
This clinical trial update indicates that the study evaluating amino acid supplementation for liver fat content and protein metabolism in ob…
-
CLINICAL_TRIALS withdrawal · 2024-07-10Clinical Trial Update: Dexamethasone/Pancreatic Clamp P&F [Phase 1]
The Phase 1 trial evaluating a dexamethasone-based pancreatic clamp for insulin resistance, prediabetes, NAFLD, and obesity has been withdra…
-
CLINICAL_TRIALS withdrawal · 2024-06-20Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects [Phase 1]
This Phase 1 trial of BAR 502 in healthy subjects intended for non-alcoholic fatty liver disease was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-11-05Clinical Trial Update: Silymarin in NAFLD [Phase 4]
Phase 4 clinical trial of silymarin in non-alcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-30Clinical Trial Update: Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver Disease [NA]
A clinical trial evaluating diaphragmatic breathing for non-alcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-28Clinical Trial Update: Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study [Phase 1]
A Phase 1 pilot trial aiming to improve insulin resistance to treat non-alcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-30Clinical Trial Update: The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients [NA]
A clinical trial evaluating the effect of acetaminophen on patients with non-alcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-30Clinical Trial Update: Non Alcoholic Fatty Liver Disease Influence of Statin Therapy [NA]
A clinical trial investigating the influence of statin therapy on non-alcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-08-28Clinical Trial Update: Natural Soybean-derived Femarelle ®for Patients With Non Alcoholic Fatty Liver Disease [Phase 4]
A Phase 4 trial of natural soybean-derived Femarelle for non-alcoholic fatty liver disease has been withdrawn.